Superior survival in diffuse large B cell lymphoma of the bone with immune rich tumor microenvironment.
Saved in:
| Title: | Superior survival in diffuse large B cell lymphoma of the bone with immune rich tumor microenvironment. |
|---|---|
| Authors: | de Groen RAL; Department of Hematology, Leiden University Medical Center, Leiden, The Netherlands., de Groot FA; Department of Hematology, Leiden University Medical Center, Leiden, The Netherlands., Böhringer S; Department of Biomedical Data Sciences, Leiden University Medical Center, Leiden, The Netherlands., Kret EJ; Department of Hematology, Leiden University Medical Center, Leiden, The Netherlands., de Haan LM; Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands., Noordenbos T; Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands.; Division of Oncology, Department of Medicine, Stanford University School of Medicine, Stanford, CA, USA., Blommers S; Department of Hematology, Leiden University Medical Center, Leiden, The Netherlands., Jansen REW; Department of Hematology, Leiden University Medical Center, Leiden, The Netherlands., van Wezel T; Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands., van Eijk R; Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands., Raghoo R; Department of Radiology, Leiden University Medical Center, Leiden, The Netherlands., Ruano D; Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands., Boome LT; Department of Internal Medicine, Haaglanden Medical Center, The Hague, The Netherlands., Terpstra V; Department of Pathology, Haaglanden Medical Center, The Hague, The Netherlands., Levenga H; Department of Internal Medicine, Groene Hart Hospital, Gouda, The Netherlands., Ahsmann E; Department of Pathology, Groene Hart Hospital, Gouda, The Netherlands., Posthuma EFM; Department of Internal Medicine, Reinier de Graaf Hospital, Delft, The Netherlands., Focke-Snieders I; Department of Pathology, Reinier de Graaf Hospital, Delft, The Netherlands., Hardi L; Department of Internal Medicine, Alrijne Hospital, Leiderdorp, The Netherlands., den Hartog WCE; Department of Pathology, Alrijne Hospital, Leiderdorp, The Netherlands., van den Berg A; Department of Pathology and Medical Biology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands., Mutsaers P; Department of Hematology, Erasmus MC Cancer Institute, University Medical Center, Rotterdam, The Netherlands., Lam K; Department of Pathology, Erasmus MC Cancer Institute, University Medical Center, Rotterdam, The Netherlands., van der Poel MWM; Department of Internal Medicine, Division of Hematology, GROW School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, The Netherlands., Hamid MA; Department of Pathology, Maastricht University Medical Center, Maastricht, The Netherlands., Woei-A-Jin FJSH; Department of General Medical Oncology, University Hospital Leuven, Leuven, Belgium., Janssens A; Department of Hematology, University Hospital Leuven, Leuven, Belgium., Tousseyn T; Department of Pathology, University Hospital Leuven, Leuven, Belgium., Bovée JVMG; Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands., Koens L; Department of Pathology, Amsterdam University Medical Center, Location University of Amsterdam, Amsterdam, The Netherlands.; Lymphoma and Myeloma Center Amsterdam-LYMMCARE, Amsterdam, The Netherlands.; Cancer Center Amsterdam, Amsterdam, The Netherlands., Diepstra A; Department of Pathology and Medical Biology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands., Cleven AHG; Department of Pathology and Medical Biology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.; Department of Pathology, Amsterdam University Medical Center, Location University of Amsterdam, Amsterdam, The Netherlands., Kersten MJ; Lymphoma and Myeloma Center Amsterdam-LYMMCARE, Amsterdam, The Netherlands.; Cancer Center Amsterdam, Amsterdam, The Netherlands.; Department of Hematology, Amsterdam University Medical Centers, Location University of Amsterdam, Amsterdam, The Netherlands., Jansen PM; Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands., Veelken H; Department of Hematology, Leiden University Medical Center, Leiden, The Netherlands., Nijland M; Department of Hematology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands., Dekker TJA; Department of Hematology, Leiden University Medical Center, Leiden, The Netherlands., Vermaat JSP; Department of Hematology, Leiden University Medical Center, Leiden, The Netherlands. j.s.p.vermaat@lumc.nl. |
| Source: | Blood cancer journal [Blood Cancer J] 2025 Apr 29; Vol. 15 (1), pp. 82. Date of Electronic Publication: 2025 Apr 29. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Nature Pub. Group Country of Publication: United States NLM ID: 101568469 Publication Model: Electronic Cited Medium: Internet ISSN: 2044-5385 (Electronic) Linking ISSN: 20445385 NLM ISO Abbreviation: Blood Cancer J Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2044-5385 |
|---|---|
| DOI: | 10.1038/s41408-025-01291-z |
